Moreover, the in vivo experiment indicated that TLR4 inhibition by a specific inhibitor (i.e., TAK-242) reversed the pro-survival role in THBS2 overexpressed CRC cells (Figures 2F, G). Here, TLR4 is linked to colorectal carcinoma.